Bio-Techne Corp (TECH)
NASDAQ NMS - GLOBAL MARKET · Biotechnology
$72.07+0.45 (+0.63%)Quote refreshed
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Market Cap
$11.28B
P/E (TTM)
—
EPS
—
Div Yield
—
52W Range
—
Beta
—
Company overview
No company overview is available for Bio-Techne Corp yet.
Peers in Biotechnology
All in industry →VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%
Recent press releases
Bio-Techne Corp has not issued a press release in this window.
SEC filings
All filings →Bio-Techne Corp has not filed an SEC document in this window.
Insider trades
All insider trades →Bio-Techne Corp has no reported insider trades in the last 90 days.
Institutional holders
All holders →As of 2025-12-31 · prior 2025-09-30
4,012,818 sh+164.4%
1,774,947 sh● NEW
MACQUARIE GROUP LTD$386,146
6,566 sh-99.6%
1,649,129 sh● NEW
MORGAN STANLEY$490.8M
8,345,414 sh+15.3%
ALLIANCEBERNSTEIN L.P.$139.1M
2,364,845 sh+157.8%
BAMCO INC /NY/$71.0M
1,207,499 sh-51.6%
MAVERICK CAPITAL LTD$226.5M
3,850,923 sh+27.8%
People at Bio-Techne Corp
All people →Quarterly financials
Full financials →Revenue trend
12/24
$27.4M
NI $34.9M
03/25
$316.2M
NI $22.6M
09/25
$286.6M
NI $38.2M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.24
Prior: $0.14
Revenue sparkline